Strides Arcolab Ltd.
Healthcare
Strides Shasun to buy Swedish firm Moberg Pharma's paediatric brand
Drugmaker Strides Shasun Ltd said on Friday it will buy Sweden-based Moberg Pharma's paediatric brand – PediaCare – for $5 ......
Healthcare
Strides Shasun to hive off bulk drugs business
Drugmaker Strides Shasun Ltd said on Wednesday it has received board approval to hive off its active pharmaceuticals ingredients (API) ......
Healthcare
Strides Shasun to buy 3 brands from Sweden's Moberg Pharma for $10M
Strides Shasun Ltd said on Monday it has agreed to acquire three brands from Sweden-based Moberg Pharma for $10 million ......
Healthcare
Strides Arcolab to buy seven brands from J&J, part of Medispan
Bangalore-based pharmaceutical company Strides Arcolab Ltd has struck a deal to acquire a bunch of brands from Johnson & Johnson ......
Healthcare
Strides Arcolab to raise up to $227M
Strides Arcolab Ltd, a Bangalore-based pharmaceutical company, has received its board’s approval to raise up to Rs 1,500 crore ($226.8 ......
Healthcare
Sun Pharma to sell two Ranbaxy units to Strides
India's top drugmaker Sun Pharmaceutical Industries Ltd has signed an agreement with Strides Arcolab Ltd to sell the erstwhile Ranbaxy’s ......
Healthcare
Strides Arcolab to buy Aspen's generic pharma business in Australia for $300M
Strides Arcolab Ltd has inked a deal to buy South African drugmaker Aspen Pharmacare's generic pharmaceutical business in Australia together ......
Healthcare
Strides Arcolab in pact with Gilead to make & distribute generic version of its HIV drug
Strides Arcolab Limited has entered into a licensing agreement with Gilead Sciences, under which Gilead has extended non-exclusive rights to ......
Healthcare
Rewind 2014: PE dealmaking in healthcare skids; M&As brighten
Healthcare sector saw private investments shrink in 2014 after hitting an all-time high the previous year. Lack of big ticket ......
Pharmaceuticals
Strides Arcolab buying Shasun Pharma in all stock deal worth over $221M
Bangalore-based Strides Arcolab Ltd, which sold its injectable-medicine unit Agila Specialties for $1.65 billion to Mylan, has struck a deal ......